Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Cash from Investing Activities (2016 - 2026)

Pharma-Bio Serv's Cash from Investing Activities history spans 17 years, with the latest figure at $2.8 million for Q1 2026.

  • For Q1 2026, Cash from Investing Activities rose 179.94% year-over-year to $2.8 million; the TTM value through Jan 2026 reached $312015.0, down 92.89%, while the annual FY2025 figure was -$1.5 million, 7.75% down from the prior year.
  • Cash from Investing Activities reached $2.8 million in Q1 2026 per PBSV's latest filing, up from -$856665.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $7.3 million in Q4 2023 to a low of -$8.2 million in Q1 2023.
  • Average Cash from Investing Activities over 5 years is -$252830.7, with a median of -$2087.0 recorded in 2022.
  • The largest YoY upside for Cash from Investing Activities was 65099.47% in 2023 against a maximum downside of 1199309.94% in 2023.
  • A 5-year view of Cash from Investing Activities shows it stood at -$12137.0 in 2022, then soared by 60469.54% to $7.3 million in 2023, then crashed by 97.66% to $171532.0 in 2024, then plummeted by 599.42% to -$856665.0 in 2025, then soared by 422.97% to $2.8 million in 2026.
  • Per Business Quant, the three most recent readings for PBSV's Cash from Investing Activities are $2.8 million (Q1 2026), -$856665.0 (Q4 2025), and $1.6 million (Q3 2025).